Main menu

London Calling 2023: Potential use of nanopore sequencing in clinical cancer genomics


Advances in sequencing technologies have transformed our understanding of cancer and ushered in a new era for cancer research. The Personalized OncoGenomics (POG) program is a prospective precision medicine initiative integrating whole-genome and transcriptome analysis (WGTA) into the clinical care of people with advanced cancers in British Columbia, Canada. In a sub-study of our larger cohort, we performed long-read Oxford Nanopore sequencing on 178 patient’s samples, in order to address some limitations we have noted with short-read sequencing. Comparison of these data sets has demonstrated situations where we now plan to apply nanopore sequencing prospectively within POG.

Authors: Janessa Laskin

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

联系我们

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

关于 Oxford Nanopore

Contact us 领导团队 媒体资源和联系方式 投资者 在 Oxford Nanopore 工作 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag